24/7 Clients Support
| Brand Name | CRIZLIEVA 250MG |
| Composition | Crizotinib Tablets 250mg |
| Manufacture By | Allieva Pharma Private Limited |
| Form | Tablet |
| Packing | Btl (60Tab) |
| Country Of Origin | India |
| Description | CRIZLIEVA 250 mg contains Crizotinib, an oral tyrosine kinase inhibitor (TKI). It targets ALK (anaplastic lymphoma kinase), ROS1, and MET receptors, inhibiting signaling pathways that drive tumor cell growth and survival. It is especially effective in ALK-positive and ROS1-positive lung cancers. |
| Uses | Crizotinib is indicated for: 1. Metastatic Non-Small Cell Lung Cancer (NSCLC) |
| Side Effects | Common side effects: • Visual disturbances (blurred vision, photopsia) • Nausea, vomiting, diarrhea • Fatigue • Edema Laboratory abnormalities: • Elevated liver enzymes Serious side effects: • Hepatotoxicity • QT interval prolongation • Interstitial lung disease (rare) • Bradycardia Regular monitoring of LFTs, ECG, and heart rate is advised. |
| Dosage | Standard adult dose: • 250 mg twice daily Continue treatment until disease progression or unacceptable toxicity.
NOTE: This medicine should be taken only under a doctor’s supervision. |